Project Grant HT94252510727
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$997K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
The Defense Health Agency awarded a $997,146.00 Project Grant to Cedars-Sinai Medical Center to investigate lesion-specific mechanisms driving retrograde transsynaptic degeneration of the visual axis in multiple sclerosis. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for Service Members and the public. The project will be conducted from September 30, 2023 to September 29, 2026 at...
The Defense Health Agency awarded a $974,043 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports early cardiac biomarker research focused on inflammation and remodeling in Duchenne muscular dystrophy. This 4-year award, running from September 1, 2025 to August 31, 2029, will fund innovative biomedical investigations at Cedars-Sinai aimed at transforming healthcare for military service members and the broader...
The Defense Health Agency awarded a $1,252,500 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the structure, function, and inhibition of the ONECUT2 protein, which is a driver of prostate cancer. The research will be conducted at Cedars-Sinai...
The Defense Health Agency awarded Cedars-Sinai Medical Center a $501,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "LARGE ONCOSOMES AS DRIVERS OF PROSTATE CANCER BONE METASTASIS", will fund advanced biomedical research aimed at transforming healthcare for military service members and the broader public. The research will investigate the role of large oncosomes in prostate cancer bone metastasis, with the goal of...
The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...
The Defense Health Agency awarded Cedars-Sinai Medical Center a $2,674,057 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective June 1, 2025 through May 31, 2029, will support advanced biomedical research to identify pathways of progression from acute pancreatitis to recurring acute pancreatitis and chronic pancreatitis. As a leading academic medical research center, Cedars-Sinai will leverage its expertise in translational research,...
Cedars-Sinai Medical Center will receive $501,000 through a two-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support the medical center's research project "CD44 Enhances Efficacy of the Chimeric Antigen Receptor T-Cell Therapy Against Prostate Cancer." Through this funding, Cedars-Sinai researchers will investigate using CD44 to improve the effectiveness of CAR T-cell therapy in treating...
The federal Project Grant award of $598,130.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Cedars-Sinai Medical Center to investigate the determinants of lung cancer-associated cachexia. The research aims to transform healthcare for military service members and the broader public by advancing innovative and impactful biomedical research. The award, effective from February 15, 2025 to February 14, 2027, will...
This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...